Patent ductus arteriosus closure: why same-dose oral ibuprofen is superior to intravenous

Thomas Bo Jensen, Jens Peter Kampmann, Jon Trærup Andersen

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Archives of Disease in Childhood. Fetal and Neonatal Edition
ISSN	1359-2998
DOI	https://doi.org/10.1136/archdischild-2019-317755
Status	Udgivet - 5 okt. 2019

Adgang til dokumentet

@article{72debf9ba6b649a3a96712a75581cda5,

title = "Patent ductus arteriosus closure: why same-dose oral ibuprofen is superior to intravenous",

keywords = "drug administration routes, ductus arteriosus, patent, ibuprofen, pharmacology, racemases and epimerases",

author = "Jensen, {Thomas Bo} and Kampmann, {Jens Peter} and {Tr{\ae}rup Andersen}, Jon",

year = "2019",

month = oct,

day = "5",

doi = "10.1136/archdischild-2019-317755",

language = "English",

journal = "Archives of Disease in Childhood. Fetal and Neonatal Edition",

issn = "1359-2998",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Patent ductus arteriosus closure

T2 - why same-dose oral ibuprofen is superior to intravenous

AU - Jensen, Thomas Bo

AU - Kampmann, Jens Peter

AU - Trærup Andersen, Jon

PY - 2019/10/5

Y1 - 2019/10/5

KW - drug administration routes

KW - ductus arteriosus, patent

KW - ibuprofen

KW - pharmacology

KW - racemases and epimerases

UR - http://www.scopus.com/inward/record.url?scp=85073411174&partnerID=8YFLogxK

U2 - 10.1136/archdischild-2019-317755

DO - 10.1136/archdischild-2019-317755

M3 - Letter

C2 - 31586941

SN - 1359-2998

JO - Archives of Disease in Childhood. Fetal and Neonatal Edition

JF - Archives of Disease in Childhood. Fetal and Neonatal Edition

ER -